Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Real-World, Retrospective Cohort Study Comparing the Effectiveness of Cell-Based Quadrivalent, Inactive Influenza Vaccine (QIVc) Versus Egg-Based, Quadrivalent, Inactive Influenza Vaccine (QIVe) in Preventing Influenza-Like Illness (ILI)

Trial Profile

A Real-World, Retrospective Cohort Study Comparing the Effectiveness of Cell-Based Quadrivalent, Inactive Influenza Vaccine (QIVc) Versus Egg-Based, Quadrivalent, Inactive Influenza Vaccine (QIVe) in Preventing Influenza-Like Illness (ILI)

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2018

At a glance

  • Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus vaccine
  • Indications Flu-like symptoms; Influenza virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2018 New trial record
    • 16 Nov 2018 According to a Seqirus media release, data from this study were presented at the recent National Foundation for Infectious Disease (NFID) 2018 Clinical Vaccinology Course.
    • 16 Nov 2018 Results presented in a Seqirus media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top